Seerlinq is taking non-invasive diagnostics, disease monitoring and treatment optimization to a new level by utilising state-of-the-art machine learning PPG analysis, and our medical expertise. Our technology has been clinically validated against right-heart catheterization and shown to reduce heart failure hospitalizations by over 50%. CE-certified as an MDR Class IIb medical device, Seerlinq is bringing predictive, preventive cardiology into every patient's home.
| Website | http://seerlinq.com |
| Employees | 29 (13 on RocketReach) |
| Founded | 2022 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Machine Learning, Non-Invasive Diagnostics, Disease Monitoring, Treatment Optimization, Medical Technology, Healthcare Technology, Health Diagnostics, Biomedical Engineering, Digital Health, Data Analytics, Predictive Analytics, Remote Patient Monitoring, Patient Monitoring, Medical Sensors, Health Monitoring, Clinical Diagnostics, Artificial Intelligence |
| Competitors | Semrush, Jasper (Formerly Jarvis), Ahrefs, apnews.com, Copy.ai, Surfer, Clearscope, Frase, Content Harmony, Topic Studios +31 more (view full list) |
Looking for a particular Seerlinq employee's phone or email?
Allan Böhm is the Chief Executive Officer, Chief Medical Officer and Founder of Seerlinq.
13 people are employed at Seerlinq.
Seerlinq is based in Bratislava, Bratislava Region.